Vernalis in second deal with Lilly

Eli Lilly (LLY) has taken an option to develop Vernalis'

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE